search
Get Started
search
Michael Heidelberger - Physician
zoom_in Click to enlarge

Michael Heidelberger

description Michael Heidelberger Overview

Michael Heidelberger was an American biochemist and immunologist recognized as one of the founding figures of immunochemistry. Through rigorous laboratory analysis in the early 20th century, he demonstrated that antibodies are specialized proteins, moving the scientific understanding of the immune system away from vague cellular theories. Collaborating with Oswald Avery, he also identified that the capsules of pneumococci bacteria are composed of complex polysaccharides, proving that these structures can function as antigens. His quantitative chemical approaches established modern immunology as a precise, measurable scientific discipline.

insights Ranking position

Michael Heidelberger ranks #113 of 150 in the Physician ranking, behind Archibald Hill, ahead of Geoffrey Harris.

help Michael Heidelberger FAQ

How did Michael Heidelberger prove that antibodies are proteins?

Heidelberger used quantitative chemical analysis of antigen-antibody precipitates to separate and measure the reacting components. His work showed that antibody activity belonged to protein molecules rather than to an undefined property of blood serum.

What did Heidelberger and Oswald Avery discover about pneumococci?

They showed that the type-specific capsules of pneumococcal bacteria contain polysaccharides that can act as antigens. This contradicted the prevailing belief that effective antigens had to be proteins.

Why is Heidelberger called a founder of immunochemistry?

He converted antibody research into a quantitative chemical discipline by measuring antigen-antibody reactions in absolute terms. Columbia University later made him its first professor of immunochemistry.

Did Heidelberger's research contribute to a pneumonia vaccine?

Yes. His work on pneumococcal polysaccharides helped support development of a multivalent vaccine tested among U.S. Army Air Forces recruits during World War II. Modern pneumococcal vaccines still rely on capsular polysaccharide antigens, often linked to carrier proteins.

Reviews & Comments

Write a Review

rate_review

Be the first to review

Share your thoughts with the community and help others make better decisions.

Save to your list

Save your favorites and follow how their scores change over time.

Save favorites
Get updates
Compare scores

Already have an account? Sign in

Compare Items

See how they stack up against each other

Comparing
VS
Select 1 more item to compare